Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,166,000 | 11,815,000 | 7,839,000 | 2,038,000 | 8,137,000 |
| Marketable Securities | N/A | N/A | N/A | 4,079,000 | N/A |
| Receivables | 7,817,000 | 7,167,000 | 6,751,000 | 7,026,000 | 7,251,000 |
| Inventories | 6,308,000 | 6,130,000 | 5,764,000 | 5,792,000 | 5,958,000 |
| Other current assets | 2,149,000 | 2,060,000 | 2,128,000 | 1,946,000 | 1,951,000 |
| TOTAL | $30,440,000 | $27,172,000 | $22,482,000 | $20,881,000 | $23,297,000 |
| Non-Current Assets | |||||
| PPE Net | 13,870,000 | 13,445,000 | 12,516,000 | 13,100,000 | 12,989,000 |
| Investments And Advances | 0 | 0 | 0 | 17,712,000 | 0 |
| Intangibles | 22,352,000 | 20,640,000 | 19,977,000 | 20,819,000 | 21,268,000 |
| Other Non-Current Assets | 24,024,000 | 23,017,000 | 22,995,000 | 5,787,000 | 24,466,000 |
| TOTAL | $60,246,000 | $57,102,000 | $55,488,000 | $57,418,000 | $58,723,000 |
| Total Assets | $90,686,000 | $84,274,000 | $77,970,000 | $78,299,000 | $82,020,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,660,000 | 4,673,000 | 4,474,000 | 5,186,000 | 8,741,000 |
| Accounts payable and accrued liabilities | 3,276,000 | 3,320,000 | 3,262,000 | 3,395,000 | 2,902,000 |
| Other current liabilities | 8,966,000 | 7,365,000 | 7,254,000 | 6,547,000 | 8,311,000 |
| TOTAL | $17,902,000 | $15,358,000 | $14,990,000 | $16,504,000 | $19,954,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,706,000 | 9,196,000 | 6,978,000 | 2,178,000 | 2,063,000 |
| Other Non-Current Liabilities | 10,751,000 | 9,223,000 | 9,761,000 | 5,026,000 | 9,255,000 |
| TOTAL | $19,471,000 | $18,428,000 | $16,752,000 | $11,358,000 | $11,329,000 |
| Total Liabilities | $37,373,000 | $33,786,000 | $31,742,000 | $27,862,000 | $31,283,000 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 959,000 | N/A |
| Retained earnings | N/A | N/A | N/A | 49,468,000 | N/A |
| Other shareholders' equity | 53,313,000 | 50,488,000 | 46,228,000 | 149,000 | 50,737,000 |
| TOTAL | $53,313,000 | $50,488,000 | $46,228,000 | $50,437,000 | $50,737,000 |
| Total Liabilities And Equity | $90,686,000 | $84,274,000 | $77,970,000 | $78,299,000 | $82,020,000 |